Using Genes to Predict Responsiveness to Cancer Drugs

Personalizing cancer treatments has long been heralded as a way to improve survivor rates and limit detrimental side effects. This is largely due to a particular patient’s level of sensitivity to the drugs prescribed. In an effort to better predict this sensitivity, researchers at MIT went digging through our DNA. Presently, there are two tactics …

Using Genes to Predict Responsiveness to Cancer Drugs Read More »